THE LUSTGARTEN FOUNDATION IS BOLDY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. SEE SCHEDULE OTHE LUSTGARTEN FOUNDATION IS BOLDY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FOCUSES ON TRANSLATING OUR UNDERSTANDING OF THE UNDERLYING BIOLOGY OF PANCREATIC CANCER INTO CLINICAL APPLICATIONS TO CHANGE, EXTEND, AND ULTIMATELY SAVE PATIENTS' LIVES. IN FY24, THE FOUNDATION AWARDED $21.8 MILLION TO FUEL CUTTING-EDGE PANCREATIC CANCER RESEARCH, INCLUDING 10 NEW GRANTS TO RESEARCHERS AT SEVEN LEADING INSTITUTIONS. RESEARCH EFFORTS ARE CONCENTRATED ON THREE KEY PILLARS: EARLY DETECTION AND INTERCEPTION, DRUG DEVELOPMENT, AND PERSONALIZED MEDICINE.
Executive compensation, broken down
Form 990 · Part VII & Schedule J · 8 reported individuals · Filing year 2023
Percentile bands compare each position's total pay with the same role at Human Services organizations in New York.
- Base
- $351k
- Bonus
- $114k
- Other
- —
- Benefits
- $37k
- Base
- $261k
- Bonus
- $68k
- Other
- —
- Benefits
- $44k
- Base
- $215k
- Bonus
- $45k
- Other
- —
- Benefits
- $49k
- Base
- $208k
- Bonus
- $43k
- Other
- —
- Benefits
- $48k
- Base
- $206k
- Bonus
- $53k
- Other
- —
- Benefits
- $35k
- Base
- $140k
- Bonus
- $17k
- Other
- —
- Benefits
- $40k
- Base
- $167k
- Bonus
- $9k
- Other
- —
- Benefits
- $16k
- Base
- $139k
- Bonus
- $17k
- Other
- —
- Benefits
- $30k
| Position | Base | Bonus | Other | Benefits | Total |
|---|---|---|---|---|---|
CEO Above 90th percentile | $351k | $114k | — | $37k | $521k $585k |
President Above 90th percentile | $261k | $68k | — | $44k | $378k $424k |
SVP Technology & Business Intelligence Senior Vice President 75th to 90th percentile | $215k | $45k | — | $49k | $322k $361k |
VP Research Board Vice President Above 90th percentile | $208k | $43k | — | $48k | $311k $349k |
CFO Above 90th percentile | $206k | $53k | — | $35k | $305k $342k |
National Director of Development Median to 75th percentile | $140k | $17k | — | $40k | $204k $229k |
Head Clinical Research & Development Highest Compensated Employee Median to 75th percentile | $167k | $9k | — | $16k | $198k $222k |
Director External & Community Relations Highest Compensated Employee Median to 75th percentile | $139k | $17k | — | $30k | $194k $218k |
Teal figures restate each filed amount in 2026 dollars.
Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Plus 19 unpaid individuals.
Top pay as a share of expenses
In 2023, the highest total compensation at MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION equaled 2% of the organization's total expenses. The median for human services organizations is 8%.
Based on 26,698 human services organizations, each measured at its most recent filing year with reported expenses and compensation.
Funded by
Private foundations whose Form 990-PF Part XV grants matched this organization.
Up 13%
from 2022
From $460k in 2022 to $521k in 2023.
Estimated with New York-Newark-Jersey City, NY-NJ-PA metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.
Chief Executive Officer pay rose 13% from 2022 to 2023, while revenue rose 24%.
- Senior Vice President pay rose 12% from 2022 to 2023.
- Board Vice President pay fell 20% from 2022 to 2023.
Pay for the position itself, not any one person. The officeholder may have changed between 2022 and 2023.
Among peers
Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.
Common questions about MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION
What does the Chief Executive Officer of MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION earn?
In 2023, the Chief Executive Officer of MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION received $520,974 in total compensation. This pay is in the top 10% for Chief Executive Officer roles among Human Services organizations in New York: at least 9 in 10 comparable filings report less. Based on IRS Form 990 data.
How does Chief Executive Officer pay at MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION compare with similar nonprofits?
Compared with the same role at Human Services organizations in New York, the 2023 pay of the Chief Executive Officer at MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION falls in the top 10%. In 2023, the highest total compensation at MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION equaled 2% of the organization's total expenses. The median for human services organizations is 8%.
What are MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION's revenue and expenses?
In 2023, MARC LUSTGARTEN PANCREATIC CANCER FOUNDATION reported $22.7M in total revenue and $31M in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.
Learn More About Nonprofit Compensation
Guides to help you understand and use this data
Nonprofit CFO Salary
What nonprofit CFOs earn, what drives the number, and how to use public compensation data in a job search or negotiation.
Read moreNonprofit Executive Director Salary
What nonprofit executive directors earn, what drives the number, and how to use public compensation data whether you are a candidate, a current ED, or a board member.
Read moreHow to Look Up Nonprofit Salaries
Two approaches to finding executive compensation at any tax-exempt organization, from raw IRS filings to searchable databases.
Read more